But Axovant said it will continue to develop nelotanserin to treat hallucinations in patients with Parkinson’s disease dementia, and is planning a larger study that could lead to FDA approval.

In the United States, the Food and Drug Administration (FDA ... including Aricept (donepezil), Exelon (rivastigmine), and Namenda (memantine) It is essential to carefully read a supplement's ...

CHICAGO--(BUSINESS WIRE)--Exelon’s local utility companies BGE ... advisory firm specializing in human and market behavior. The study evaluates utility companies’ ability to deliver effective ...

Four Exelon companies have earned placement among ... data analytics and advisory firm specializing in human and market behavior. The study evaluates utility companies’ ability to deliver ...

CHICAGO (AP) — CHICAGO (AP) — Exelon Corp. (EXC) on Wednesday reported fourth-quarter earnings of $647 million. On a per-share basis, the Chicago-based company said it had profit of 64 cents.

Exelon Corporation EXC is scheduled to release fourth-quarter 2024 results on Feb. 12, before market open. The company delivered an earnings surprise of 5.97% in the last reported quarter. Exelon ...

Hello, and welcome to Exelon's Fourth Quarter Earnings Call. My name is Michelle, and I will be your event specialist today. [Operator Instructions] Please note that today's webcast is being recorded.

BMO Capital raised the firm’s price target on Exelon (EXC) to $46 from $44 and keeps an Outperform rating on the shares ahead of its Q4 results. The firm expects a robust capital plan update ...

(Reuters) -Major U.S. electric utility Exelon increased its four-year capital investment plan by 10% to $38 billion, with the bulk of the spending aimed at bolstering and building new transmission ...

Investing.com -- S&P Global has upgraded the issuer credit rating of Exelon Corp (NASDAQ:EXC). and its utility subsidiary PECO Energy Inc. to 'A-' from 'BBB+', following a review of the companies ...